MS-275 to modulate NK cell response against Osteosarcoma. Implication of the chemokines CXCL9/CXCL10

Uchechi Norah Asika, The University of Texas MD Anderson Cancer Center
Ariana Rupp Anjier, The University of Texas MD Anderson Cancer Center
Yuanzheng Yang, The University of Texas MD Anderson Cancer Center
Pradeep Shrestha, The University of Texas MD Anderson Cancer Center
Anchit Bhagat, The University of Texas MD Anderson Cancer Center
Nancy Gordon, The University of Texas MD Anderson Cancer Center

Description